PIM
VRX

Perkins Investment Management’s VALEANT PHARMACEUTICALS INTL VRX Stock Holding History

Perkins Investment Management’s Portfolio VRX Stock Details VRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-25,000
Closed -$4.97M – 284
2015
Q1 		$4.97M Buy
+25,000
New +$4.97M 0.05% 201

Other funds holding VRX

CG
Colony Group Boston, Massachusetts $6.66B AUM 18.65% 1-Year Est. Return

Perkins Investment Management's VRX Position: Q2 2015 in Review

Perkins Investment Management sold out of VALEANT PHARMACEUTICALS INTL (VRX) in Q2 2015, closing a stake of 25,000 shares — an estimated $4.97M sold.

Perkins Investment Management first reported a position in VRX in Q1 2015 and held it in 1 quarter. The position peaked at $4.97M in Q1 2015. 1 fund tracked by Wall St. Rank holds VRX as of Q2 2015.

  • Perkins Investment Management reported no remaining VALEANT PHARMACEUTICALS INTL position as of Q2 2015 after selling out during the quarter.
  • Perkins Investment Management sold 25,000 VALEANT PHARMACEUTICALS INTL shares in Q2 2015, an estimated $4.97M.
  • Perkins Investment Management first reported a position in VALEANT PHARMACEUTICALS INTL in Q1 2015 and held it in 1 quarter.
  • Perkins Investment Management's VALEANT PHARMACEUTICALS INTL position peaked at $4.97M in Q1 2015.
  • 1 fund tracked by Wall St. Rank held VALEANT PHARMACEUTICALS INTL as of Q2 2015.

Based on Perkins Investment Management's 13F filing for Q2 2015, filed 17 Aug 2015.